| scholarly article | Q13442814 |
| P2093 | author name string | Jeffrey A Kant | |
| Qingmei Xie | |||
| Jill M Hagenkord | |||
| Federico A Monzon | |||
| Shera F Kash | |||
| Stan Lilleberg | |||
| P2860 | cites work | Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays | Q21563517 |
| Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations | Q24598248 | ||
| Runs of homozygosity in European populations | Q24642367 | ||
| Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia | Q24642439 | ||
| Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML | Q24645177 | ||
| The application of single nucleotide polymorphism microarrays in cancer research | Q24653582 | ||
| Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia | Q24657747 | ||
| Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays | Q24676798 | ||
| Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 | ||
| B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions | Q28201835 | ||
| Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia | Q28206302 | ||
| Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene | Q28216381 | ||
| Genome-wide copy number profiling on high-density bacterial artificial chromosomes, single-nucleotide polymorphisms, and oligonucleotide microarrays: a platform comparison based on statistical power analysis | Q28293141 | ||
| Allelic dosage analysis with genotyping microarrays. | Q34429361 | ||
| Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. | Q34575412 | ||
| Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization. | Q34720177 | ||
| Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia | Q34745382 | ||
| Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies | Q35230221 | ||
| The signatures of autozygosity among patients with colorectal cancer. | Q35247248 | ||
| Hot-spot mutants of p53 core domain evince characteristic local structural changes. | Q35549859 | ||
| Whole genome DNA copy number changes identified by high density oligonucleotide arrays | Q36475181 | ||
| Genetic alteration associated with chronic lymphocytic leukemia | Q37000305 | ||
| Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas | Q37180251 | ||
| Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders | Q37271438 | ||
| Uniparental disomy in cancer | Q37402117 | ||
| Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies | Q37534893 | ||
| High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray | Q39852653 | ||
| Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. | Q40123066 | ||
| V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. | Q44083652 | ||
| Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies | Q44631635 | ||
| Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia | Q57369840 | ||
| Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia | Q57537886 | ||
| Chronic lymphocytic leukemia | Q72059563 | ||
| Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia | Q73387920 | ||
| Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis | Q78077743 | ||
| Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival | Q80709731 | ||
| Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia | Q81523534 | ||
| Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia | Q83214944 | ||
| The rewards and challenges of array-based karyotyping for clinical oncology applications | Q83815683 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| karyotype | Q189967 | ||
| lymphocyte | Q715347 | ||
| chronic lymphocytic leukemia | Q1088156 | ||
| P304 | page(s) | 184-96 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | The Journal of Molecular Diagnostics | Q7743603 |
| P1476 | title | Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays | |
| P478 | volume | 12 |
| Q33818637 | Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants |
| Q35748382 | Age-related somatic structural changes in the nuclear genome of human blood cells |
| Q57783666 | American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders |
| Q33397024 | Array CGH in human leukemia: from somatics to genetics |
| Q36029469 | Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus |
| Q37618663 | Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia? |
| Q33567169 | Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma |
| Q39582693 | Copy number variation and selection during reprogramming to pluripotency |
| Q36799831 | Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia. |
| Q48575290 | Development of locus specific sub-clone separation by fluorescence in situ hybridization in suspension in chronic lymphocytic leukemia |
| Q34608117 | Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis. |
| Q39686496 | Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis |
| Q38061177 | Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies |
| Q38001406 | Genome-wide arrays in routine diagnostics of hematological malignancies |
| Q36737322 | Genomic approaches to chronic lymphocytic leukemia |
| Q58010100 | Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescencein situhybridization techniques? |
| Q35906949 | Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis. |
| Q37528942 | Identification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling |
| Q47305045 | Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome |
| Q43488736 | Microarray-based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia |
| Q33931096 | Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues |
| Q37936087 | SNP array analysis in constitutional and cancer genome diagnostics--copy number variants, genotyping and quality control |
| Q46087353 | Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities. |
| Q37781972 | The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas |
| Q38088010 | The role of high-throughput technologies in clinical cancer genomics |
| Q37924989 | The role of molecular genetic analysis within the diagnostic haemato-oncology laboratory |
| Q40609808 | The vanguard has arrived in the clinical laboratory: array-based karyotyping for prognostic markers in chronic lymphocytic leukemia |
Search more.